Abstract
The controversial point of treatment for oropharyngeal cancer is the surgical approach and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The approach without mandibulotomy allows for simple reconstruction and has a low complication rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative approach and refinement of oropharuyngectomy in the future.
Keywords: Advanced oropharyngeal carcinoma, mandibulotomy, transcervical oropharyngectomy.
Graphical Abstract
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Current Drug Metabolism
Related Books
Anthocyanins: Pharmacology and Nutraceutical Importance
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Frontiers in Clinical Drug Research - Anti-Cancer Agents
The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach
Advanced Pharmacy
24
1
1
1